1. Home
  2. ENVA vs ERAS Comparison

ENVA vs ERAS Comparison

Compare ENVA & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$238.08

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$18.53

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
ERAS
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.0B
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
ENVA
ERAS
Price
$238.08
$18.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
$185.71
$14.25
AVG Volume (30 Days)
464.8K
5.5M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
55.05
36.23
EPS
3.46
N/A
Revenue
$3,151,653,000.00
N/A
Revenue This Year
$149.64
N/A
Revenue Next Year
$16.42
N/A
P/E Ratio
$68.28
N/A
Revenue Growth
18.58
N/A
52 Week Low
$99.61
$1.33
52 Week High
$246.38
$24.28

Technical Indicators

Market Signals
Indicator
ENVA
ERAS
Relative Strength Index (RSI) 71.53 67.85
Support Level $156.53 $12.36
Resistance Level $246.38 $24.28
Average True Range (ATR) 9.19 1.20
MACD -0.09 0.22
Stochastic Oscillator 85.11 77.71

Price Performance

Historical Comparison
ENVA
ERAS

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: